Earnings and valuation of Replimune Group Inc (REPL) Stock are impressive

Piper Sandler raised the price target for the Replimune Group Inc (NASDAQ:REPL) stock to “an Overweight”. The rating was released on April 17, 2023, according to finviz. The research report from BTIG Research has resumed the stock to Buy, with a price target set at $60. The stock was initiated by BTIG Research, who disclosed […]

Invest in Replimune Group Inc (REPL) Stock with the prospect of future returns

Piper Sandler raised the price target for the Replimune Group Inc (NASDAQ:REPL) stock to “an Overweight”. The rating was released on April 17, 2023, according to finviz. The research report from BTIG Research has resumed the stock to Buy, with a price target set at $60. The stock was initiated by BTIG Research, who disclosed […]

Growing at an Unbelievable Rate: Replimune Group Inc (REPL) Stock

Piper Sandler raised the price target for the Replimune Group Inc (NASDAQ:REPL) stock to “an Overweight”. The rating was released on April 17, 2023, according to finviz. The research report from BTIG Research has resumed the stock to Buy, with a price target set at $60. The stock was initiated by BTIG Research, who disclosed […]

Why Replimune Group Inc (NASDAQ:REPL) Stock Jumped 21.70% in Last Month?

Piper Sandler raised the price target for the Replimune Group Inc (NASDAQ:REPL) stock to “an Overweight”. The rating was released on April 17, 2023, according to finviz. The research report from BTIG Research has resumed the stock to Buy, with a price target set at $60. The stock was initiated by BTIG Research, who disclosed […]

Replimune Group Inc (REPL) Stock Experiences Incredible Growth

Piper Sandler raised the price target for the Replimune Group Inc (NASDAQ:REPL) stock to “an Overweight”. The rating was released on April 17, 2023, according to finviz. The research report from BTIG Research has resumed the stock to Buy, with a price target set at $60. The stock was initiated by BTIG Research, who disclosed […]

Yummy or too sour? Replimune Group Inc (REPL) Stock

Piper Sandler raised the price target for the Replimune Group Inc (NASDAQ:REPL) stock to “an Overweight”. The rating was released on April 17, 2023, according to finviz. The research report from BTIG Research has resumed the stock to Buy, with a price target set at $60. The stock was initiated by BTIG Research, who disclosed […]

Replimune Group Inc (REPL) Stock at a key inflection point

Piper Sandler raised the price target for the Replimune Group Inc (NASDAQ:REPL) stock to “an Overweight”. The rating was released on April 17, 2023, according to finviz. The research report from BTIG Research has resumed the stock to Buy, with a price target set at $60. The stock was initiated by BTIG Research, who disclosed […]

It’s an all-out bull run for Replimune Group Inc (REPL) Stock

Piper Sandler raised the price target for the Replimune Group Inc (NASDAQ:REPL) stock to “an Overweight”. The rating was released on April 17, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]

Are Options A Good Investment Right Now? Replimune Group Inc (REPL) Stock

Piper Sandler raised the price target for the Replimune Group Inc (NASDAQ:REPL) stock to “an Overweight”. The rating was released on April 17, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]